Feiyan Cheng

机构：First Affiliated Hospital of Xi'an Jiaotong University

发表论文 15 篇 · 总被引 257 次 · h-index 9

代表论文

• A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say? (2023 · Frontiers in Pharmacology · 被引 53)
• FTO protects human granulosa cells from chemotherapy-induced cytotoxicity (2022 · Reproductive Biology and Endocrinology · 被引 48)
• FGF2 Is Protective Towards Cisplatin-Induced KGN Cell Toxicity by Promoting FTO Expression and Autophagy (2022 · Frontiers in Endocrinology · 被引 39)
• Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy (2023 · World Journal of Surgical Oncology · 被引 29)
• Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expression (2024 · Reproductive Biology and Endocrinology · 被引 23)
• FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway (2024 · Molecular and Cellular Endocrinology · 被引 13)